A Combination of Caffeine Supplementation and Enriched Environment in an Alzheimer's Disease Mouse Model.
Alzheimer’ disease
Aβ4-42
amyloid-β
behavior
caffeine
neuron loss
physical activity
transgenic mice
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
21 Jan 2023
21 Jan 2023
Historique:
received:
21
12
2022
revised:
12
01
2023
accepted:
20
01
2023
entrez:
11
2
2023
pubmed:
12
2
2023
medline:
15
2
2023
Statut:
epublish
Résumé
A variety of factors has been associated with healthy brain aging, and epidemiological studies suggest that physical activity and nutritional supplements such as caffeine may reduce the risk of developing dementia and, in particular, Alzheimer's disease (AD) in later life. Caffeine is known to act as a cognitive enhancer but has been also shown to positively affect exercise performance in endurance activities. We have previously observed that chronic oral caffeine supplementation and a treatment paradigm encompassing physical and cognitive stimulation by enriched environment (EE) housing can improve learning and memory performance and ameliorate hippocampal neuron loss in the Tg4-42 mouse model of AD. Here, we investigated whether these effects were synergistic. To that end, previous findings on individual treatments were complemented with unpublished, additional data and analyzed in depth by ANOVA followed by Bonferroni multiple comparison post tests. We further evaluated whether plasma neurofilament light chain levels reflect neuropathological and behavioral changes observed in the experimental groups. While a treatment combining physical activity and caffeine supplementation significantly improved learning and memory function compared to standard-housed vehicle-treated Tg4-42 in tasks such as the Morris water maze, no major additive effect outperforming the effects of the single interventions was observed.
Identifiants
pubmed: 36768476
pii: ijms24032155
doi: 10.3390/ijms24032155
pmc: PMC9916825
pii:
doi:
Substances chimiques
Caffeine
3G6A5W338E
Amyloid beta-Peptides
0
Amyloid beta-Protein Precursor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Gerhard Hunsmann Stiftung
ID : T0323/28817
Organisme : Deutsche Forschungsgemeinschaft
ID : WI3472/10-1; ME1648/11-1
Organisme : Alzheimer Forschung Initiative
ID : 20021
Références
Alzheimers Res Ther. 2018 Jul 28;10(1):71
pubmed: 30055655
Behav Brain Res. 2021 Jan 15;397:112951
pubmed: 33027669
Mayo Clin Proc. 2011 Sep;86(9):876-84
pubmed: 21878600
Eur J Clin Nutr. 2007 Feb;61(2):226-32
pubmed: 16929246
Exp Neurol. 2007 Jan;203(1):241-5
pubmed: 17007839
Acta Neuropathol. 2010 Aug;120(2):185-93
pubmed: 20419305
Mol Neurobiol. 2021 Jan;58(1):204-216
pubmed: 32914393
Diabetes Care. 2014 Feb;37(2):569-86
pubmed: 24459154
Oxid Med Cell Longev. 2021 Aug 17;2021:5568011
pubmed: 34447487
Sci Rep. 2020 Nov 18;10(1):20095
pubmed: 33208869
BMJ. 2021 Aug 18;374:n1804
pubmed: 34407988
Front Sports Act Living. 2020 Dec 11;2:574854
pubmed: 33345139
Exp Physiol. 2017 Nov 1;102(11):1356-1371
pubmed: 28786150
Neurobiol Learn Mem. 2007 Oct;88(3):277-94
pubmed: 17714960
Neurobiol Dis. 2011 Aug;43(2):486-94
pubmed: 21569847
Neurobiol Aging. 2007 Jun;28(6):831-44
pubmed: 16730391
J Neuropathol Exp Neurol. 2003 Dec;62(12):1220-7
pubmed: 14692698
FASEB J. 2020 Aug;34(8):10998-11014
pubmed: 32619083
J Alzheimers Dis. 2009;17(3):681-97
pubmed: 19581723
Nutrients. 2022 Jul 21;14(14):
pubmed: 35889953
Sci Rep. 2019 Dec 23;9(1):19644
pubmed: 31873185
Cell. 2005 Mar 11;120(5):701-13
pubmed: 15766532
Nat Neurosci. 1999 Mar;2(3):266-70
pubmed: 10195220
Neurology. 2007 Aug 7;69(6):536-45
pubmed: 17679672
Nat Protoc. 2013 Dec;8(12):2531-7
pubmed: 24263092
Transl Psychiatry. 2016 May 03;6:e800
pubmed: 27138799
Med Sci Sports Exerc. 2008 Oct;40(10):1841-51
pubmed: 18799996
J Alzheimers Dis. 2009;17(3):661-80
pubmed: 19581722
Ann Med. 2015 Mar;47(2):81-7
pubmed: 25613168
J Neurosci Methods. 1984 May;11(1):47-60
pubmed: 6471907
Neurobiol Aging. 2012 Jan;33(1):96-107
pubmed: 20359774
J Alzheimers Dis. 2009;16(1):85-91
pubmed: 19158424
Neuroscience. 2006 Nov 3;142(4):941-52
pubmed: 16938404
J Neurosci. 2005 Apr 27;25(17):4217-21
pubmed: 15858047
Learn Mem. 2009 Dec 22;17(1):5-11
pubmed: 20028732
J Alzheimers Dis. 2021;80(3):1151-1168
pubmed: 33646155
Br J Sports Med. 2020 Jun;54(11):681-688
pubmed: 30926628
Front Cell Dev Biol. 2020 Sep 08;8:806
pubmed: 33015033
J Neurosci Methods. 2010 Jun 15;189(2):180-5
pubmed: 20359499
Neurobiol Aging. 2014 Sep;35(9):2079-90
pubmed: 24780254
Learn Mem. 2011 Aug 30;18(9):605-9
pubmed: 21878528
J Neurosci. 2005 May 25;25(21):5217-24
pubmed: 15917461
Transl Psychiatry. 2019 Oct 22;9(1):270
pubmed: 31641100
Cell Mol Life Sci. 2021 Dec 16;79(1):55
pubmed: 34913091
Nat Rev Neurosci. 2019 Apr;20(4):235-245
pubmed: 30723309
Behav Brain Res. 2017 Jan 15;317:332-339
pubmed: 27702635
Acta Neuropathol. 2013 Aug;126(2):189-205
pubmed: 23685882
Eur Arch Psychiatry Clin Neurosci. 2022 Jun 9;:
pubmed: 35676374
Front Behav Neurosci. 2019 May 17;13:107
pubmed: 31156407
Physiol Behav. 2011 Mar 28;102(5):475-80
pubmed: 21236277
JAMA Neurol. 2022 Oct 1;79(10):1059-1063
pubmed: 36066874
J Neurochem. 2016 Dec;139(6):1019-1055
pubmed: 27365148
Exp Neurol. 2013 Oct;248:470-81
pubmed: 23920241
Biochem Biophys Res Commun. 2007 May 18;356(4):976-80
pubmed: 17400186
Nutrients. 2021 Feb 06;13(2):
pubmed: 33562156
Sci Rep. 2015 Dec 02;5:17338
pubmed: 26626428
Neuropharmacology. 2009 May-Jun;56(6-7):994-1000
pubmed: 19217915
J Alzheimers Dis. 2012;30(3):559-72
pubmed: 22430531
Neurology. 2017 May 9;88(19):1788-1794
pubmed: 28404801
CNS Neurosci Ther. 2017 Apr;23(4):272-290
pubmed: 28317317
Mol Med Rep. 2013 Sep;8(3):737-40
pubmed: 23900282
Sports Med. 2018 Aug;48(8):1913-1928
pubmed: 29876876
Nat Rev Neurosci. 2006 Sep;7(9):697-709
pubmed: 16924259
Eur J Neurosci. 2005 Jan;21(1):1-14
pubmed: 15654838
Circulation. 2015 Dec 15;132(24):2305-15
pubmed: 26572796
PLoS Med. 2021 Nov 16;18(11):e1003830
pubmed: 34784347
Cogn Process. 2012 May;13(2):93-110
pubmed: 22160349
F1000Res. 2019 Sep 6;8:1601
pubmed: 31723422
Front Mol Neurosci. 2016 Aug 03;9:62
pubmed: 27536216
BMJ Open. 2017 Oct 22;7(10):e014706
pubmed: 29061599
Mol Neurobiol. 2017 Oct;54(8):6542-6555
pubmed: 27734334
Int J Sports Med. 1999 Aug;20(6):354-61
pubmed: 10496113
Psychopharmacology (Berl). 2016 May;233(10):1963-79
pubmed: 26786412
Neuroreport. 2004 Aug 6;15(11):1751-4
pubmed: 15257141